BNN Bloomberg Market Call featuring Dennis da Silva from Middlefield

Diabetes and Obesity Stocks to Buy in 2023: Rob Moffat – BNN Bloomberg Hot Picks

Middlefield Portfolio Manager Rob Moffat discusses how Ozempic and other weight loss drugs will drive growth in the biopharma industry.

  • BNN Bloomberg
  • Diabetes and Obesity Stocks to Buy in 2023: Rob Moffat – BNN Bloomberg Hot Picks
M-Asset
  • BNN Bloomberg
  • Diabetes and Obesity Stocks to Buy in 2023: Rob Moffat – BNN Bloomberg Hot Picks
Close
Subscribe to Our Insights!
Flyout Form

Close
Subscribe for MCT Updates
Flyout Form UK